Lamicet is a phenyltriazine antiepileptic used to treat some types of epilepsy and bipolar disorder. Lamicet controls epileptic seizures by inhibiting voltage-sensitive sodium channels, thereby stabilizes neuronal membranes and consequently inhibits presynaptic excitatory neurotransmitter (e.g., glutamate and aspartate) release.